Clinical Trial Update: Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dual-targeting CAR-NK cells for recurrent or progressive glioblastoma and high-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma
• Malignant Glioma

Drugs mentioned

• Dual-targeting CAR-NK cells (CAR-NK cells)

Snippet

Sponsor: Beijing Biotech | Conditions: Glioblastoma, High-grade Glioma | Phase 1 | Status: RECRUITING